PharmaSens announced today that it appointed Dr. Robert A. Gabbay and James L. Peterson to its board of directors. Gabbay joins the board of the Swiss company after spending time in leadership roles with the American Diabetes Association (ADA). Peterson spent more than two decades as a medtech CEO and more recently served as executive […]
PharmaSens
These diabetes devices are set to launch in 2024
The diabetes space continues to innovate, and it doesn’t look like that’s stopping any time soon, with 2024 set to be another banner year. At the end of 2023, we compiled a list of the 10 biggest diabetes technology stories of the year. Some of those stories didn’t end in 2023, though, as a few […]
PharmaSens submits insulin patch pump for FDA approval
PharmaSens announced today that it submitted an application for FDA approval for its Niia Essential insulin patch pump system. FDA submission follows the pump’s recent ISO 13485 certification for the Switzerland-based company. This encompassed the entire process of design, development, manufacturing and distribution for insulin infusion pumps and accessories. Niia Essential, the first of three […]
